Cannara Biotech Inc. (TSX:LOVE)
Canada · Delayed Price · Currency is CAD 1.670
-0.010 (-0.60%)
Jun 8, 2026, 3:38 PM EST
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 165.95 million as of June 8, 2026. Its market cap has increased by 45.20% in one year.
Market Cap
165.95M
Enterprise Value
178.28M
Revenue
113.01M
Ranking
n/a
PE Ratio
15.45
Stock Price
1.67
Market Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 165.95M, a decrease of -21.58%. That is a compound annual growth rate of -3.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 165.95M | 0.41% |
| Dec 31, 2025 | 165.28M | 148.11% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TerrAscend | 321.94M |
| Aurora Cannabis | 277.90M |
| Auxly Cannabis Group | 229.37M |
| Organigram Global | 208.14M |
| Cardiol Therapeutics | 175.64M |
| BioSyent | 156.70M |
| Ascend Wellness Holdings | 155.49M |
| Grown Rogue International | 152.46M |